According to NICE Technology Appraisal 875, Wegovy should be prescribed within a specialist weight management service, with a maximum treatment duration of 2 years, and continued only if at least 5% weight loss is achieved at 6 months
Second, and most importantly, muscle and heart have a low capacity for activating medium-chain fatty acids to coenzyme A (CoA), which is a prerequisite step for fatty acid -oxidation
The escalation ladders are different in structure, but the principle is the same: start low, increase every 30 days, and stop at the dose that works best for the patient
PlexusDx provides transparency on this sourcing as part of its precision-wellness framework
Safety and Clinical Management Safety trials of GLP-1 RAs, including liraglutide, tirzepatide, and semaglutide (oral or subcutaneous), indicate that the most common adverse events (AEs) of treatment are mild to moderate gastrointestinal including nausea, vomiting, diarrhea, constipation, dyspepsia, and decreased appetite
